Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2016

01-09-2016 | Original Article

Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals

Authors: D. Delle Rose, P. Pezzotti, E. Fortunato, P. Sordillo, S. Gini, S. Boros, M. Meledandri, M. T. Gallo, G. Prignano, R. Caccese, M. D’Ambrosio, G. Citterio, M. Rocco, F. Leonardis, S. Natoli, C. Fontana, M. Favaro, M. G. Celeste, T. Franci, G. P. Testore, M. Andreoni, L. Sarmati

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2016

Login to get access

Abstract

The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients’ risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients’ conditions on the onset of this infection. A total of 1,647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24–13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03–4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram- species was detected in the respiratory specimens.
Literature
1.
go back to reference Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903CrossRefPubMed Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903CrossRefPubMed
2.
go back to reference Wilke M, Grube R (2014) Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy. Infect Drug Resist 7:1–7 Wilke M, Grube R (2014) Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy. Infect Drug Resist 7:1–7
3.
go back to reference American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. ATS/IDSA. Am J Respir Crit Care Med 171:388–416 American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. ATS/IDSA. Am J Respir Crit Care Med 171:388–416
4.
go back to reference Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K et al (2008) Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 12:R56CrossRefPubMedPubMedCentral Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K et al (2008) Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care 12:R56CrossRefPubMedPubMedCentral
5.
go back to reference Kollef MH, Von Harz B, Prentice D, Shapiro SD, Silver P, St John R et al (1997) Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest 112:765–773CrossRefPubMed Kollef MH, Von Harz B, Prentice D, Shapiro SD, Silver P, St John R et al (1997) Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest 112:765–773CrossRefPubMed
6.
go back to reference Sandiumenge A, Rello J (2012) Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 18:187–193CrossRefPubMed Sandiumenge A, Rello J (2012) Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 18:187–193CrossRefPubMed
8.
go back to reference Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P et al (2015) Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect 70:213–222CrossRefPubMed Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P et al (2015) Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect 70:213–222CrossRefPubMed
9.
go back to reference Wroblewska MM, Rudnicka J, Marchel H, Luczak M (2006) Multidrug-resistant bacteria isolated from patients hospitalised in intensive care units. Int J Antimicrob Agents 27:285–289CrossRefPubMed Wroblewska MM, Rudnicka J, Marchel H, Luczak M (2006) Multidrug-resistant bacteria isolated from patients hospitalised in intensive care units. Int J Antimicrob Agents 27:285–289CrossRefPubMed
10.
go back to reference Denys GA, Relich RF (2014) Antibiotic resistance in nosocomial respiratory infections. Clin Lab Med 34:257–270CrossRefPubMed Denys GA, Relich RF (2014) Antibiotic resistance in nosocomial respiratory infections. Clin Lab Med 34:257–270CrossRefPubMed
11.
go back to reference CLSI (2010) Performance standard for antimicrobial susceptibily testing; twenty-first information supplement. CLSI M100, S20 CLSI (2010) Performance standard for antimicrobial susceptibily testing; twenty-first information supplement. CLSI M100, S20
12.
go back to reference Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure-time data, 2nd edn. Wiley, New YorkCrossRef Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure-time data, 2nd edn. Wiley, New YorkCrossRef
13.
go back to reference Medell M, Hart M, Duquesne A, Espinosa F, Valdés R (2013) Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance. MEDICC Rev 15:26–29PubMed Medell M, Hart M, Duquesne A, Espinosa F, Valdés R (2013) Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance. MEDICC Rev 15:26–29PubMed
14.
go back to reference Quartin AA, Scerpella EG, Puttagunta S, Kett DH (2013) A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis 13:561. doi:10.1186/1471-2334-13-561 CrossRefPubMedPubMedCentral Quartin AA, Scerpella EG, Puttagunta S, Kett DH (2013) A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study. BMC Infect Dis 13:561. doi:10.​1186/​1471-2334-13-561 CrossRefPubMedPubMedCentral
16.
go back to reference Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F et al (2006) Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 64:16–22CrossRefPubMed Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F et al (2006) Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 64:16–22CrossRefPubMed
18.
go back to reference Uçkay I, Ahmed QA, Sax H, Pittet D (2008) Ventilator-associated pneumonia as a quality indicator for patient safety? Clin Infect Dis 46:557–563CrossRefPubMed Uçkay I, Ahmed QA, Sax H, Pittet D (2008) Ventilator-associated pneumonia as a quality indicator for patient safety? Clin Infect Dis 46:557–563CrossRefPubMed
19.
go back to reference Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC (2008) National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 36:609–626CrossRefPubMed Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC (2008) National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 36:609–626CrossRefPubMed
20.
go back to reference Bouadma L, Deslandes E, Lolom I, Le Corre B, Mourvillier B, Regnier B et al (2010) Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 51:1115–1122CrossRefPubMed Bouadma L, Deslandes E, Lolom I, Le Corre B, Mourvillier B, Regnier B et al (2010) Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 51:1115–1122CrossRefPubMed
21.
go back to reference Klompas M, Kulldorff M, Platt R (2008) Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 46:1443–1446CrossRefPubMed Klompas M, Kulldorff M, Platt R (2008) Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 46:1443–1446CrossRefPubMed
22.
go back to reference Gadani H, Vyas A, Kar AK (2010) A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. India J Anaesth 54:535–540CrossRef Gadani H, Vyas A, Kar AK (2010) A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. India J Anaesth 54:535–540CrossRef
23.
go back to reference Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP (2014) Ventilator-associated pneumonia in a tertiary care intensive care unit: analysis of incidence, risk factors and mortality. India J Crit Care Med 18:200–204CrossRef Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP (2014) Ventilator-associated pneumonia in a tertiary care intensive care unit: analysis of incidence, risk factors and mortality. India J Crit Care Med 18:200–204CrossRef
24.
go back to reference Hui X, Haider AH, Hashmi ZG, Rushing AP, Dhiman N, Scott VK et al (2013) Increased risk of pneumonia among ventilated patients with traumatic brain injury: every day counts! J Surg Res 184:438–443CrossRefPubMed Hui X, Haider AH, Hashmi ZG, Rushing AP, Dhiman N, Scott VK et al (2013) Increased risk of pneumonia among ventilated patients with traumatic brain injury: every day counts! J Surg Res 184:438–443CrossRefPubMed
25.
go back to reference Decelle L, Thys F, Zech F, Verschuren F (2013) Ventilation-associated pneumonia after intubation in the prehospital or the emergency unit. Eur J Emerg Med 20:61–63CrossRefPubMed Decelle L, Thys F, Zech F, Verschuren F (2013) Ventilation-associated pneumonia after intubation in the prehospital or the emergency unit. Eur J Emerg Med 20:61–63CrossRefPubMed
26.
go back to reference Jovanovic B, Milan Z, Markovic-Denic L, Djuric O, Radinovic K, Doklestic K et al (2015) Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. Int J Infect Dis 38:46–51CrossRefPubMed Jovanovic B, Milan Z, Markovic-Denic L, Djuric O, Radinovic K, Doklestic K et al (2015) Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. Int J Infect Dis 38:46–51CrossRefPubMed
27.
go back to reference Plurad DS, Kim D, Bricker S, Lemesurier L, Neville A, Bongard F et al (2013) Ventilator-associated pneumonia in severe traumatic brain injury: the clinical significance of admission chest computed tomography findings. J Surg Res 183:371–376CrossRefPubMed Plurad DS, Kim D, Bricker S, Lemesurier L, Neville A, Bongard F et al (2013) Ventilator-associated pneumonia in severe traumatic brain injury: the clinical significance of admission chest computed tomography findings. J Surg Res 183:371–376CrossRefPubMed
28.
go back to reference Gianakis A, McNett M, Belle J, Moran C, Grimm D (2015) Risk factors for ventilator-associated pneumonia: among trauma patients with and without brain injury. J Trauma Nurs 22:125–131CrossRefPubMed Gianakis A, McNett M, Belle J, Moran C, Grimm D (2015) Risk factors for ventilator-associated pneumonia: among trauma patients with and without brain injury. J Trauma Nurs 22:125–131CrossRefPubMed
29.
go back to reference Zhu S, Cai L, Ma C, Zeng H, Guo H, Mao X et al (2015) The clinical impact of ventilator-associated events: a prospective multi-center surveillance study. Infect Control Hosp Epidemiol 27:1–8 Zhu S, Cai L, Ma C, Zeng H, Guo H, Mao X et al (2015) The clinical impact of ventilator-associated events: a prospective multi-center surveillance study. Infect Control Hosp Epidemiol 27:1–8
30.
go back to reference Boyer AF, Schoenberg N, Babcock H, McMullen KM, Micek ST, Kollef MH (2015) A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest 147:68–81CrossRefPubMed Boyer AF, Schoenberg N, Babcock H, McMullen KM, Micek ST, Kollef MH (2015) A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest 147:68–81CrossRefPubMed
31.
go back to reference Safdar N, Dezfulian C, Collard HR, Saint S (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33:2184–2193CrossRefPubMed Safdar N, Dezfulian C, Collard HR, Saint S (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33:2184–2193CrossRefPubMed
32.
go back to reference Efrati S, Deutsch I, Antonelli M, Hockey PM, Rozenblum R, Gurman GM (2010) Ventilator-associated pneumonia: current status and future recommendations. J Clin Monit Comput 24:161–168CrossRefPubMed Efrati S, Deutsch I, Antonelli M, Hockey PM, Rozenblum R, Gurman GM (2010) Ventilator-associated pneumonia: current status and future recommendations. J Clin Monit Comput 24:161–168CrossRefPubMed
33.
go back to reference Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP (2014) Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int 2014:305784CrossRefPubMedPubMedCentral Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP (2014) Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int 2014:305784CrossRefPubMedPubMedCentral
34.
go back to reference Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M et al (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431CrossRefPubMed Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M et al (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413–431CrossRefPubMed
35.
go back to reference European Centre for Disease Prevention and Control (ECDC) (2012) Antimicrobial resistance surveillance in Europe 2011. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm European Centre for Disease Prevention and Control (ECDC) (2012) Antimicrobial resistance surveillance in Europe 2011. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm
36.
go back to reference Corcione S, Rocchetti A, Argentero PA, Raso R, Zotti CM, De Rosa FG et al (2015) A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU. Clin Microbiol Infect 21:e11–e13CrossRefPubMed Corcione S, Rocchetti A, Argentero PA, Raso R, Zotti CM, De Rosa FG et al (2015) A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU. Clin Microbiol Infect 21:e11–e13CrossRefPubMed
37.
go back to reference Corbellini S, Caccuri F, Gelmi M, De Francesco MA, Fiorentini S, Caruso A et al (2014) Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. New Microbiol 37:177–183PubMed Corbellini S, Caccuri F, Gelmi M, De Francesco MA, Fiorentini S, Caruso A et al (2014) Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. New Microbiol 37:177–183PubMed
38.
go back to reference Parisi SG, Bartolini A, Santacatterina E, Castellani E, Ghirardo R, Berto A et al (2015) Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis 15:244CrossRefPubMedPubMedCentral Parisi SG, Bartolini A, Santacatterina E, Castellani E, Ghirardo R, Berto A et al (2015) Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis 15:244CrossRefPubMedPubMedCentral
39.
go back to reference Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R (2009) Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30:666–671CrossRefPubMed Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R (2009) Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30:666–671CrossRefPubMed
40.
go back to reference Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Canadian Critical Care Trials Group et al (2008) Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 23:18–26CrossRefPubMed Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Canadian Critical Care Trials Group et al (2008) Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 23:18–26CrossRefPubMed
41.
go back to reference Chittawatanarat K, Jaipakdee W, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T (2014) Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist 7:203–210CrossRefPubMedPubMedCentral Chittawatanarat K, Jaipakdee W, Chotirosniramit N, Chandacham K, Jirapongcharoenlap T (2014) Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist 7:203–210CrossRefPubMedPubMedCentral
42.
go back to reference Terraneo S, Ferrer M, Martín-Loeches I, Esperatti M, Di Pasquale M, Giunta V et al (2016) Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clin Microbiol Infect 22:94.e1-8CrossRefPubMed Terraneo S, Ferrer M, Martín-Loeches I, Esperatti M, Di Pasquale M, Giunta V et al (2016) Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia. Clin Microbiol Infect 22:94.e1-8CrossRefPubMed
43.
go back to reference Khorvash F, Abbasi S, Yaran M, Abdi F, Ataei B, Fereidooni F et al (2014) Molecular detection of Candida spp. and Aspergillus fumigatus in bronchoalveolar lavage fluid of patients with ventilator-associated pneumonia. J Res Med Sci 19:S46–S50PubMedPubMedCentral Khorvash F, Abbasi S, Yaran M, Abdi F, Ataei B, Fereidooni F et al (2014) Molecular detection of Candida spp. and Aspergillus fumigatus in bronchoalveolar lavage fluid of patients with ventilator-associated pneumonia. J Res Med Sci 19:S46–S50PubMedPubMedCentral
44.
go back to reference Tan X, Zhu S, Yan D, Chen W, Chen R, Zou J et al (2016) Candida spp. airway colonization: a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol. 2016 Mar 21. pii: myw009. [Epub ahead of print] Tan X, Zhu S, Yan D, Chen W, Chen R, Zou J et al (2016) Candida spp. airway colonization: a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol. 2016 Mar 21. pii: myw009. [Epub ahead of print]
Metadata
Title
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals
Authors
D. Delle Rose
P. Pezzotti
E. Fortunato
P. Sordillo
S. Gini
S. Boros
M. Meledandri
M. T. Gallo
G. Prignano
R. Caccese
M. D’Ambrosio
G. Citterio
M. Rocco
F. Leonardis
S. Natoli
C. Fontana
M. Favaro
M. G. Celeste
T. Franci
G. P. Testore
M. Andreoni
L. Sarmati
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2694-9

Other articles of this Issue 9/2016

European Journal of Clinical Microbiology & Infectious Diseases 9/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.